跳至主要内容
临床试验/NCT07397026
NCT07397026进行中(未招募)1 期

Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial

Hagar Ahmed Ali Mohammed Elzain1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2025年8月9日最近更新:
干预措施

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
48
试验地点
1
主要终点
Clinical attachment level (CAL) as Clinical periodontal parameter

研究概览

简要总结

The Aim of this study is to test the effectiveness of locally applied resveratrol as an adjunct to scaling and root planing in the treatment of periodontitis (primary outcome) . Also to assess the level of COX-2 and superoxide dismutase (SOD) in the gingival crevicular fluid samples using the commercially available kits.

详细描述

Patients who are accepted for this study will be screened by a comprehensive periodontal examination and full periodontal charts. Proper Diagnosis of the stages of periodontitis will be based on the new classification proposed in 2017 AAP World Workshop.

  • Clinical periodontal parameters, including:
  1. Plaque Index (PI), according to Silness P. Loe H 1964.
  2. Gingival Index (GI), according to Silness P. Loe H 1963.
  3. Eastman Interdental Bleeding Index (EIBI), according to Ainamo & Bay 1975 .
  4. Clinical Attachment Level (CAL) is measured from cemento enemal junction to base of the pocket.
  5. Probing Pocket Depth(PPD) is measured from free gingival margin to base of the pocket.

ALL these parameters will be assessed at baseline and after 3 months after treatment for groups 2, 3 and 4 while at baseline only for group 1.

  • GCF samples will be collected using sterile paper strips and analyzed using the commercially available kits for the assessment of the level of COX-2 and SOD at baseline and after 3 months after treatment for groups 2, 3 and 4 while at baseline only for group 1.

After proper and accurate examination and diagnosis, full mouth supra- and subgingival SRP will be performed with ultrasonic tips and Gracey curettes (Hu-Friedy, Chicago, United States) and an ultrasonic device (Minipiezon, EMS [Electro Medical System], Le Sentier, Switzerland). All patients will receive oral hygiene instructions. After completion of SRP, RES loaded gel will be injected in the selected periodontal pocket of the test group (group 4) while RES unloaded gel will be injected as placebo gel in group 3 using a syringe with a blunt cannula until the pocket will be completely filled.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient 25-55 years.
  • Presence of ≥20 teeth.
  • PPD >3&≤5 mm.
  • The patients are in good systemic health.
  • Patients have not received any periodontal surgery in the areas that will be assessed in the last 6 months

排除标准

  • Patients with systemic diseases.
  • Pregnant and lactating women.
  • Heavy Smokers and tobacco chewers.
  • Patients do not follow oral hygiene measures.
  • Patients with a known or suspected allergy to any material used in the study.

研究组 & 干预措施

Group 1 (negative control group): includes 12 periodontally healthy subjects

No Intervention

Healthy Patients who are accepted for this study will be screened by a comprehensive periodontal examination and full periodontal charts. Proper Diagnosis of the stages of periodontitis will be based on the new classification proposed in 2017 AAP World Workshop.

  • Clinical periodontal parameters, including:
  1. Plaque Index (PI), according to Silness P. Loe H 1964.
  2. Gingival Index (GI), according to Silness P. Loe H 1963.
  3. Eastman Interdental Bleeding Index (EIBI), according to Ainamo & Bay 1975.
  4. Clinical Attachment Level (CAL) is measured from cemento enemal junction to base of the pocket.
  5. Probing Pocket Depth(PPD) is measured from free gingival margin to base of the pocket.

ALL these parameters will be assessed at baseline.

  • GCF samples will be collected using sterile paper strips and analyzed using the commercially available kits for the assessment of the level of COX-2 and SOD at baseline .

no injection of Resveratrol Loaded Nanoparticles .

Group 2(positive control group): includes 12 patients will be treated with Scaling and root planing

Sham Comparator

Patients who are accepted for this study will be screened by periodontal examination and full periodontal charts. Proper Diagnosis of the stages of periodontitis will be based on the new classification proposed in 2017

  • Clinical periodontal parameters, including:
  1. Plaque Index (PI) .
  2. Gingival Index(GI) .
  3. Eastman Interdental Bleeding Index (EIBI) .
  4. Clinical Attachment Level (CAL) .
  5. Probing Pocket Depth(PPD) is measured from free gingival margin to base of the pocket.

ALL these parameters will be assessed at baseline and after 3 months after treatment .

  • GCF samples will be collected using sterile paper strips and analyzed using the commercially available kits for the assessment of the level of COX-2 and SOD at baseline and after 3 months after treatment .

After proper and accurate examination and diagnosis, full mouth supra- and subgingival SRP will be performed with ultrasonic tips and Gracey curettes .

patients will receive oral hygiene instructions.

干预措施: Resveratrol loaded gel (Drug)

Group 3 (placebo group): includes 12 patients will be treated with Resveratrol unloaded gel

Placebo Comparator

Patients who are accepted for this study will be screened by periodontal examination and full periodontal charts. Proper Diagnosis of the stages of periodontitis will be based on the new classification proposed in 2017

  • Clinical periodontal parameters, including:
  1. PI .
  2. GI .
  3. EIBI .
  4. CAL .
  5. PPD.
  • GCF samples will be collected using sterile paper strips and analyzed using the commercially available kits for the assessment of the level of COX-2 and SOD at baseline and after 3 months after treatment .

After diagnosis, full mouth supra- and subgingival SRP will be performed with ultrasonic tips and Gracey curettes .

patients will receive oral hygiene instructions.

After completion of SRP, RES unloaded gel will be injected as placebo gel in using a syringe with a blunt cannula until the pocket will be completely filled.

the Patients will be instructed to avoid chewing hard, eating any sticky foods for several hours.

No intervention of Resveratrol Loaded Nanoparticles .

干预措施: Resveratrol loaded gel (Drug)

Group 4 (Resveratrol Loaded Nanoparticles):12 patients will be injected with Resveratrol loaded gel

Other

Patients who are accepted for this study will be screened by periodontal examination and full periodontal charts. Proper Diagnosis of the stages of periodontitis will be based on the new classification proposed in 2017

  • Clinical periodontal parameters, including:
  1. PI .
  2. GI .
  3. EIBI .
  4. CAL .
  5. PPD.
  • GCF samples will be collected using sterile paper strips and analyzed using the commercially available kits for the assessment of the level of COX-2 and SOD at baseline and after 3 months after treatment .

After diagnosis, full mouth supra- and subgingival SRP will be performed with ultrasonic tips and Gracey curettes .

patients will receive oral hygiene instructions.

After completion of SRP, Resveratrol loaded nanoparticles gel will be injected in the selected periodontal pocket using a syringe with a blunt cannula until the pocket will be completely filled.

there is intervention by injection of Resveratrol Loaded Nanoparticles inside the pocket .

干预措施: Resveratrol loaded gel (Drug)

结局指标

主要结局

Clinical attachment level (CAL) as Clinical periodontal parameter

时间窗: 3 months

Patients who are accepted for this study will be screened by periodontal examination and full periodontal charts. Proper Diagnosis of the stages of periodontitis will be based on the new classification proposed in 2017. Clinical attachment level (CAL) as Clinical periodontal parameter in mm

次要结局

  • laboratory evaluation of Cox-2 & SOD in GCF(3 months)

研究者

发起方
Hagar Ahmed Ali Mohammed Elzain
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hagar Ahmed Ali Mohammed Elzain

clinical demonstrator faculty of dentistry Mansoura university

Mansoura University

研究点 (1)

Loading locations...

相似试验